SE9003564L - Laekemedel, vilka som aktiv substans innehaaller karboxylsyror innehaallande svavel samt deras anvaendning foer bekaempning av retrovirus - Google Patents

Laekemedel, vilka som aktiv substans innehaaller karboxylsyror innehaallande svavel samt deras anvaendning foer bekaempning av retrovirus

Info

Publication number
SE9003564L
SE9003564L SE9003564A SE9003564A SE9003564L SE 9003564 L SE9003564 L SE 9003564L SE 9003564 A SE9003564 A SE 9003564A SE 9003564 A SE9003564 A SE 9003564A SE 9003564 L SE9003564 L SE 9003564L
Authority
SE
Sweden
Prior art keywords
combating
retrovirus
pharmaceuticals
carboxylic acids
active substance
Prior art date
Application number
SE9003564A
Other languages
English (en)
Swedish (sv)
Other versions
SE9003564D0 (sv
SE508601C2 (sv
Inventor
J Kalden
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of SE9003564D0 publication Critical patent/SE9003564D0/xx
Publication of SE9003564L publication Critical patent/SE9003564L/
Publication of SE508601C2 publication Critical patent/SE508601C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
SE9003564A 1989-11-09 1990-11-08 Läkemedel, vilka som aktiv substans innehåller karboxylsyror innehållande svavel samt deras användning för bekämpning av retrovirus SE508601C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3937325 1989-11-09
DE4015728 1990-05-16

Publications (3)

Publication Number Publication Date
SE9003564D0 SE9003564D0 (sv) 1990-11-08
SE9003564L true SE9003564L (sv) 1991-06-07
SE508601C2 SE508601C2 (sv) 1998-10-19

Family

ID=25886910

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003564A SE508601C2 (sv) 1989-11-09 1990-11-08 Läkemedel, vilka som aktiv substans innehåller karboxylsyror innehållande svavel samt deras användning för bekämpning av retrovirus

Country Status (19)

Country Link
US (1) US5334612A ( )
EP (1) EP0427246B1 ( )
JP (1) JPH03188021A ( )
AT (2) AT500684B8 ( )
BE (2) BE1003834A5 ( )
CA (1) CA2029599C ( )
CH (1) CH684054A5 ( )
DE (3) DE9017987U1 ( )
DK (3) DK0427246T3 ( )
ES (2) ES2076279T3 ( )
FR (1) FR2653997B1 ( )
GB (1) GB2239797B ( )
GR (3) GR1001503B ( )
IE (1) IE67874B1 ( )
IT (1) IT1246328B ( )
LU (1) LU87834A1 ( )
NL (1) NL9002438A ( )
PT (1) PT95827B ( )
SE (1) SE508601C2 ( )

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59209162D1 (de) * 1991-07-05 1998-03-05 Asta Medica Ag Verwendung von Schwefel enthaltenden Carbonsäuren zur Bekämpfung von pathophysiologisch bedingten Erregungsstörungen
DE4201196C2 (de) * 1992-01-18 1997-05-15 Rabien Margarethe Arzneimittel zur Behandlung der Polyneuropathie
DE4320117A1 (de) * 1992-01-18 1994-12-22 Margarethe Rabien Kombinatinspräparate
DE9321574U1 (de) * 1992-03-11 2000-06-29 Asta Medica Ag Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
DE9213914U1 ( ) * 1992-10-15 1992-12-03 Asta Medica Ag, 6000 Frankfurt, De
CA2159116A1 (en) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
DE4317173C2 (de) * 1993-05-22 1995-06-14 Asta Medica Ag Verwendung von Dihydroliponsäure als Ophthalmologicum
DE4345199C2 (de) * 1993-05-22 1995-10-12 Asta Medica Ag Verwendung von Dihydroliponsäure zur Unterdrückung von Unverträglichkeitsreaktionen im Grenzbereich von Implantaten mit lebendem Körpergewebe
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten
US5463093A (en) * 1993-11-26 1995-10-31 Garnett; Merrill Palladium complexes and methods for using same in the treatment of tumors or Psoriasis
DE4433764A1 (de) 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
DE4439480C1 (de) * 1994-11-08 1996-06-05 Asta Medica Ag Verwendung von D,L- alpha-Liponsäure und/oder ihren Enantiomeren, und/oder ihren Derivaten als Zusatz bei Erythrozyten-Flüssigkonserven für homologe und autologe Erythrozyten-Konzentrate und als Zusatz bei Erythrozyten-Kryokonserven für homologe und autologe Erythrozytenkonzentrate
EP1023284B1 (en) * 1996-07-05 2005-11-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds
WO1998023606A1 (fr) * 1996-11-27 1998-06-04 Fuji Kagaku Kogyo Kabushiki Kaisha Derives dithio cycliques, remedes contre des maladies renales diabetiques, agents hypoglycemiques, agents hypolipidemiques et agents lenitifs contre les troubles digestifs
US6090842A (en) * 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US6905707B2 (en) * 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
US20040259895A1 (en) * 1998-05-28 2004-12-23 Medical Research Institute Oral formulation of lipid soluble thiamine and lipoic acid
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US6136339A (en) 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
CA2352144A1 (en) * 1998-11-25 2000-06-02 Yissum Research Development Company Of The Hebrew University In Jerusale M Scavenger compounds
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
DE10045904B4 (de) * 1999-10-01 2007-07-12 Degussa Gmbh alpha-Liponsäure(-Derivate) enthaltende Retardform
WO2001024795A1 (de) * 1999-10-01 2001-04-12 Skw Trostberg Aktiengesellschaft α-LIPONSÄURE(-DERIVATE)ENTHALTENDE RETARDFORM
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
ATE320833T1 (de) * 2000-06-06 2006-04-15 Verwendung von einem liponsaüren -(r)- enantiomeren in kosmetika und dermatologie
DE10027968A1 (de) * 2000-06-08 2001-12-13 Asta Medica Ag Mittel zur Therapie von Demenzen
US6683110B1 (en) 2001-05-23 2004-01-27 University Of Central Florida Methyl esters of substituted 4-oxo-2-butenoic acid for treatment of tuberculosis
US6649610B1 (en) 2001-05-23 2003-11-18 University Of Central Florida 2-oxo-1, 4-benzoxazine compounds for treatment of tuberculosis
US6686496B1 (en) 2001-06-08 2004-02-03 University Of Central Florida Treatment of myeloma
US6602907B1 (en) 2001-06-08 2003-08-05 University Of Central Florida Treatment of breast cancer
US6852876B1 (en) 2001-06-08 2005-02-08 University Of Central Florida Treatment of colon cancer
WO2003072052A2 (en) * 2002-02-22 2003-09-04 Albany College Of Pharmacy Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
US7030154B2 (en) * 2002-06-07 2006-04-18 Juvenon, Inc. Stability of lipoic acid
DE10229995A1 (de) * 2002-07-03 2004-01-15 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an alpha-Liponsäure
US20040133938A1 (en) * 2002-11-19 2004-07-08 Yinghui Dan Use of lipoic acid in plant culture media
DE10318045A1 (de) * 2003-04-17 2004-11-04 Basf Ag Stabile Ammoniumsalze der alpha-Liponsäure, ihre Herstellung und Verwendung
JP4716666B2 (ja) * 2003-05-21 2011-07-06 有限会社オガ リサーチ α−リポ酸含有水性製剤
CN100422134C (zh) * 2004-03-12 2008-10-01 北京天衡药物研究院 新的2-（α-正戊酮基）苯甲酸盐及其制法和用途
US20060213815A1 (en) * 2005-01-28 2006-09-28 Wille John J Hydrocarbon fume suppression by higher vapor pressure temperature oils
WO2006134609A2 (en) * 2005-06-16 2006-12-21 Mmi Corporation Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof
JP2009525289A (ja) * 2006-01-31 2009-07-09 パルスロース カンパニー 免疫調節特性を有する薬草抽出物
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
EA200901011A1 (ru) * 2009-06-08 2010-12-30 Общество С Ограниченной Ответственностью "Научно-Производственный Центр Белагроген" Препарат на основе интерферона
CN107820422B (zh) * 2015-05-21 2022-02-08 摩纳哥奥夫塔尔米斯公司 包含硫辛酸和类粘液状聚合物的眼用组合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA901960A (en) * 1972-06-06 Rossler Richard PROCESS FOR STABILIZING .alpha.-LIPOIC ACID IN PHARMACEUTICAL SOLUTIONS
US2840505A (en) * 1954-04-09 1958-06-24 Du Pont Process of treating animals for metal poisoning with thio-compounds
US2875227A (en) * 1955-05-11 1959-02-24 Merck & Co Inc Ephedrine salts of 7-carboethoxy-3-acetylthioheptanoic acid
US2933430A (en) * 1959-01-22 1960-04-19 Du Pont Lipoic acid compositions
DE1617740B1 (de) * 1967-09-25 1971-11-04 Pfrimmer & Co J Verfahren zum Stabilisieren von Alfa-Liponsäure
DE1668887B2 (de) * 1968-03-15 1976-06-16 Ca-salz der 1,2 -dithia-cyclopentan - 3- valerian saeure gleich (thioctsaeure)
ZA716628B (en) * 1970-10-15 1972-06-28 Richardson Merrell Spa Composition and method for treatment of hepatic disease and mental fatigue
JPS5026516A ( ) * 1973-07-07 1975-03-19
US4100150A (en) * 1975-11-04 1978-07-11 G. D. Searle & Co. Stabilization of interferon against mechanical stress using thioctic acid
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
EP0127012A3 (en) * 1983-05-30 1987-05-27 Suntory Limited Antimutagenic agent and a method of reducing mutagenicity
CH656382A5 (de) * 1983-10-24 1986-06-30 Sandoz Ag Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung.
JPS60146829A (ja) * 1984-01-05 1985-08-02 Rooto Seiyaku Kk テストステロン５α−リダクタ−ゼ阻害剤
JPS60184011A (ja) * 1984-03-02 1985-09-19 Itaru Yamamoto 免疫調節剤
EP0159519A3 (de) * 1984-03-29 1987-02-04 Asta-Werke Aktiengesellschaft Chemische Fabrik Verwendung von Thioverbindungen zur Verhinderung des durch Cytostatika verursachten Haarausfalls
DE3608606A1 (de) * 1985-03-16 1986-09-18 The Wellcome Foundation Ltd., London 3'-azido-3'-deoxythymidin oder eine, ein pharmazeutisch vertraegliches derivat davon enthaltende pharmazeutische formulierung, verfahren zu ihrer herstellung und ihre verwendung
DE3512911A1 (de) * 1985-04-11 1986-10-16 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von 1,2-dithiolan-3-pentansaeure (thioctsaeure)
DE3615710A1 (de) * 1986-05-09 1987-11-26 Hoechst Ag Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
JP2543096B2 (ja) * 1987-09-24 1996-10-16 松下電器産業株式会社 燃焼装置
EP0318891B1 (de) * 1987-12-04 1992-01-02 ASTA Medica Aktiengesellschaft Injizierbare Lösung des Thioctsäuresalzes mit Trometamol und/oder basischen Aminosäuren
DE3840076A1 (de) * 1987-12-04 1989-06-15 Asta Pharma Ag Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren
JPH01203336A (ja) * 1988-02-09 1989-08-16 Teikoku Seiyaku Kk 経皮・口腔粘膜適用製剤
EP0382066A3 (de) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
DE4002706A1 (de) * 1989-02-09 1990-08-16 Asta Pharma Ag Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
EP0812590A3 (de) * 1989-11-09 1999-06-09 ASTA Medica Aktiengesellschaft Verwendung von R-Alpha-Liponsäure zur Zytoprotektion
JPH10203336A (ja) * 1997-01-17 1998-08-04 Aisin Seiki Co Ltd アンチスキッド制御装置

Also Published As

Publication number Publication date
PT95827A (pt) 1991-09-13
IE904035A1 (en) 1991-05-22
GB9024252D0 (en) 1990-12-19
FR2653997A1 (fr) 1991-05-10
SE9003564D0 (sv) 1990-11-08
PT95827B (pt) 1997-11-28
DK267790A (da) 1991-05-10
LU87834A1 (de) 1991-05-07
IT1246328B (it) 1994-11-17
DE59009497D1 (de) 1995-09-14
AT500684A1 (de) 2006-02-15
AT500684B8 (de) 2006-11-15
ES2029769A6 (es) 1992-09-01
BE1005018A3 (fr) 1993-03-23
DK0427246T3 (da) 1995-11-27
EP0427246A2 (de) 1991-05-15
GR1001503B (el) 1994-02-28
GB2239797A (en) 1991-07-17
CA2029599A1 (en) 1991-05-10
EP0427246A3 (en) 1992-06-03
DK200001239A (da) 2000-08-22
NL9002438A (nl) 1991-06-03
AT500684B1 (de) 2006-10-15
DK173585B1 (da) 2001-04-02
DE9017987U1 (de) 1993-12-09
JPH03188021A (ja) 1991-08-16
IE67874B1 (en) 1996-05-01
BE1003834A5 (fr) 1992-06-23
IT9048456A1 (it) 1992-05-08
CA2029599C (en) 1998-08-11
CH684054A5 (de) 1994-07-15
SE508601C2 (sv) 1998-10-19
ATE126053T1 (de) 1995-08-15
DK173752B1 (da) 2001-09-10
FR2653997B1 (fr) 1995-01-20
GR1000918B (el) 1993-03-16
DK267790D0 (da) 1990-11-08
GR900100796A (en) 1992-04-17
IT9048456A0 (it) 1990-11-08
US5334612A (en) 1994-08-02
ES2076279T3 (es) 1995-11-01
EP0427246B1 (de) 1995-08-09
GB2239797B (en) 1994-06-15
GR3017695T3 (en) 1996-01-31
DE4035456A1 (de) 1991-05-16

Similar Documents

Publication Publication Date Title
SE9003564L (sv) Laekemedel, vilka som aktiv substans innehaaller karboxylsyror innehaallande svavel samt deras anvaendning foer bekaempning av retrovirus
KR890701559A (ko) 3-인돌피루브산 유도체 및 그의 제약 용도
KR890011592A (ko) 기관내 허혈병의 치료용 조성물
KR890016966A (ko) 신규 항바이러스제
GR3026161T3 (en) Use of sulfur containing carboxylic acids for combatting pathophysiologic excitatory disorders
PL312683A1 (en) Pharmaceutical solutions free of organic salts for nasal administration
FI821253A0 (fi) Galenisk produkt
DE69031340D1 (de) 3'-azido-2',3'-dideoxy-5-methylcytidin enthaltende antivirale zusammensetzungen
KR970061249A (ko) 골다공증을 치료 또는 방지하기 위한 조성물
CH661865A5 (it) Composizioni farmaceutiche ad attivita antineoplastica.
DE69600272D1 (de) Chinolin-4-carbonylguanidin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
KR870007937A (ko) 2β-치환된 티오 메틸페니실린 유도체 및 그의 제조방법 및 용도
KR900012925A (ko) 인돌 유도체
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
ZA933455B (en) Thiochroman compounds, processes for the preparation thereof and pharmaceutical compositions containing them
JPH0437803B2 ( )
KR910004192A (ko) 프로페니토인의 치료적 유효량을 함유하는 발작증 치료용 제약 조성물
US4391809A (en) Methods for treating psoriasis
PT97164A (pt) Processo para a estabilizacao de uma preparacao que contenham o composto 4-etil-2-hidroxi-imino-5-nitro-3-hexenamida e de composicoes farmaceuticas que o contenham
KR870001144A (ko) Nn-디메틸에틸옥사이드가 함유된 약제조성물 및 그의 생산방법
ATE270T1 (de) Neue n1-benzoyl-n2-phenyl-1,3-diaminopropan-2-ole und ihre salze; verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel.
KR930004647B1 (ko) 신장 질환 치료제
KR880012577A (ko) 티아디아졸 구아니딘 화합물 및 이의 제조방법
IT9048063A1 (it) Composizioni farmaceutiche a base di calcitonina somministrabili per via nasale
JPH0558883A (ja) 医薬組成物

Legal Events

Date Code Title Description
NUG Patent has lapsed